Susan M. Catalano, Ph.D.
Affiliations: | Cognition Therapeutics Inc. |
Area:
Alzheimer's therapeuticsWebsite:
http://www.cogrx.comGoogle:
"Susan Catalano"Mean distance: 13.05 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Carla J. Shatz | post-doc | 1993-1998 | Cognition Therapeutics Inc. |
| Mary B. Kennedy | post-doc | 1998-1999 | Cognition Therapeutics Inc. |
Children
Sign in to add trainee| Courtney Rehak | research assistant | 2008- | Cognition Therapeutics |
| Kelsie A. Mozzoni | research assistant | 2011- | Cognition Therapeutics |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Colom-Cadena M, Toombs J, Simzer E, et al. (2024) Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease. Acta Neuropathologica. 147: 32 |
| van Dyck CH, Mecca AP, O'Dell RS, et al. (2024) A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease. Alzheimer's Research & Therapy. 16: 20 |
| Lizama BN, Kahle J, Catalano SM, et al. (2023) Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases. International Journal of Molecular Sciences. 24 |
| Rishton GM, Look GC, Ni ZJ, et al. (2021) Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease. Acs Medicinal Chemistry Letters. 12: 1389-1395 |
| LaBarbera KM, Limegrover C, Rehak C, et al. (2021) Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery. Journal of Neuroscience Methods. 358: 109180 |
| Izzo NJ, Yuede CM, LaBarbera KM, et al. (2021) Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Limegrover CS, Yurko R, Izzo NJ, et al. (2021) Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein. Journal of Neuroscience Research |
| Izzo NJ, Colom-Cadena M, Riad AA, et al. (2020) Proceedings from the Fourth International Symposium on sigma-2 Receptors: Role in Health and Disease. Eneuro |
| Limegrover CS, LeVine H, Izzo NJ, et al. (2020) Alzheimer's Protection Effect of A673T Mutation May Be Driven by Lower Aβ Oligomer Binding Affinity. Journal of Neurochemistry |
| Colom-Cadena M, Spires-Jones T, Zetterberg H, et al. (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease. Alzheimer's Research & Therapy. 12: 21 |